Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways
Glypican-3 (GPC3) is a proteoglycan involved in proliferation and cell survival. Several reports demonstrated that GPC3 is downregulated in some tumors, such as breast cancer. Previously, we determined that GPC3 reexpression in the murine mammary adenocarcinoma LM3 cells induced an impairment of the...
| Autores: | , , , , , , , |
|---|---|
| Tipo de documento: | artigo |
| Estado: | Versão publicada |
| Data de publicação: | 2010 |
| País: | Argentina |
| Recursos: | Consejo Nacional de Investigaciones Científicas y Técnicas |
| Repositório: | CONICET Digital (CONICET) |
| Idioma: | inglês |
| OAI Identifier: | oai:ri.conicet.gov.ar:11336/117735 |
| Acesso em linha: | http://hdl.handle.net/11336/117735 |
| Access Level: | Acceso aberto |
| Palavra-chave: | APOPTOSIS BREAST CANCER GLYPICAN-3 P38MAPK PATHWAY PI3K/AKT PATHWAY https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| id |
AR_0d6436ca2ba3c10a7d692bdf2b248ff1 |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/117735 |
| network_acronym_str |
AR |
| network_name_str |
Argentina |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways |
| title |
Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways |
| spellingShingle |
Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways Buchanan, Cecilia APOPTOSIS BREAST CANCER GLYPICAN-3 P38MAPK PATHWAY PI3K/AKT PATHWAY https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| title_short |
Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways |
| title_full |
Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways |
| title_fullStr |
Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways |
| title_full_unstemmed |
Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways |
| title_sort |
Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways |
| dc.creator.none.fl_str_mv |
Buchanan, Cecilia Stigliano, Ivan Daniel Garay Malpartida, H. M. Rodrigues Gomes, L. Puricelli, Lydia Ines Sogayar, M.C. Bal, Elisa Dora Peters, María Giselle |
| author |
Buchanan, Cecilia |
| author_facet |
Buchanan, Cecilia Stigliano, Ivan Daniel Garay Malpartida, H. M. Rodrigues Gomes, L. Puricelli, Lydia Ines Sogayar, M.C. Bal, Elisa Dora Peters, María Giselle |
| author_role |
author |
| author2 |
Stigliano, Ivan Daniel Garay Malpartida, H. M. Rodrigues Gomes, L. Puricelli, Lydia Ines Sogayar, M.C. Bal, Elisa Dora Peters, María Giselle |
| author2_role |
author author author author author author author |
| dc.subject.none.fl_str_mv |
APOPTOSIS BREAST CANCER GLYPICAN-3 P38MAPK PATHWAY PI3K/AKT PATHWAY https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| topic |
APOPTOSIS BREAST CANCER GLYPICAN-3 P38MAPK PATHWAY PI3K/AKT PATHWAY https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
| description |
Glypican-3 (GPC3) is a proteoglycan involved in proliferation and cell survival. Several reports demonstrated that GPC3 is downregulated in some tumors, such as breast cancer. Previously, we determined that GPC3 reexpression in the murine mammary adenocarcinoma LM3 cells induced an impairment of their invasive and metastatic capacities, associated with a decrease of their motility and an increase of their cell death. We demonstrated that GPC3 inhibits canonical Wnt signaling, as well as it activates non canonical pathway. Now, we identified signaling pathways responsible for the pro-apoptotic role of GPC3 in LM3 cells. We found for the first time that GPC3 inhibits the PI3K/Akt anti-apoptotic pathway while it stimulates the p38MAPK stress-activated one. We report a concomitant modulation of CDK inhibitors as well as of pro- and anti-apoptotic molecules. Our results provide new clues regarding the mechanism involved in the modulation induced by GPC3 of mammary tumor cell growth and survival. |
| publishDate |
2010 |
| dc.date.none.fl_str_mv |
2010-02 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/117735 Buchanan, Cecilia; Stigliano, Ivan Daniel; Garay Malpartida, H. M.; Rodrigues Gomes, L.; Puricelli, Lydia Ines; et al.; Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways; Springer; Breast Cancer Research and Treatment; 119; 3; 2-2010; 559-574 0167-6806 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/117735 |
| identifier_str_mv |
Buchanan, Cecilia; Stigliano, Ivan Daniel; Garay Malpartida, H. M.; Rodrigues Gomes, L.; Puricelli, Lydia Ines; et al.; Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways; Springer; Breast Cancer Research and Treatment; 119; 3; 2-2010; 559-574 0167-6806 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007/s10549-009-0362-9 info:eu-repo/semantics/altIdentifier/doi/10.1007/s10549-009-0362-9 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Springer |
| publisher.none.fl_str_mv |
Springer |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1799195246948515840 |
| spelling |
Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathwaysBuchanan, CeciliaStigliano, Ivan DanielGaray Malpartida, H. M.Rodrigues Gomes, L.Puricelli, Lydia InesSogayar, M.C.Bal, Elisa DoraPeters, María GiselleAPOPTOSISBREAST CANCERGLYPICAN-3P38MAPK PATHWAYPI3K/AKT PATHWAYhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Glypican-3 (GPC3) is a proteoglycan involved in proliferation and cell survival. Several reports demonstrated that GPC3 is downregulated in some tumors, such as breast cancer. Previously, we determined that GPC3 reexpression in the murine mammary adenocarcinoma LM3 cells induced an impairment of their invasive and metastatic capacities, associated with a decrease of their motility and an increase of their cell death. We demonstrated that GPC3 inhibits canonical Wnt signaling, as well as it activates non canonical pathway. Now, we identified signaling pathways responsible for the pro-apoptotic role of GPC3 in LM3 cells. We found for the first time that GPC3 inhibits the PI3K/Akt anti-apoptotic pathway while it stimulates the p38MAPK stress-activated one. We report a concomitant modulation of CDK inhibitors as well as of pro- and anti-apoptotic molecules. Our results provide new clues regarding the mechanism involved in the modulation induced by GPC3 of mammary tumor cell growth and survival.Fil: Buchanan, Cecilia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; ArgentinaFil: Stigliano, Ivan Daniel. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; ArgentinaFil: Garay Malpartida, H. M.. Universidade de Sao Paulo; BrasilFil: Rodrigues Gomes, L.. Universidade de Sao Paulo; BrasilFil: Puricelli, Lydia Ines. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; ArgentinaFil: Sogayar, M.C.. Universidade de Sao Paulo; BrasilFil: Bal, Elisa Dora. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; ArgentinaFil: Peters, María Giselle. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; ArgentinaSpringer2010-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/117735Buchanan, Cecilia; Stigliano, Ivan Daniel; Garay Malpartida, H. M.; Rodrigues Gomes, L.; Puricelli, Lydia Ines; et al.; Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways; Springer; Breast Cancer Research and Treatment; 119; 3; 2-2010; 559-5740167-6806CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007/s10549-009-0362-9info:eu-repo/semantics/altIdentifier/doi/10.1007/s10549-009-0362-9info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2024-05-08T13:47:03Zoai:ri.conicet.gov.ar:11336/117735instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982024-05-08 13:47:03.275CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| score |
15,811543 |